| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA753365 | F | In vivo antimalarial activity as survivors after 1 month in chloroquine-resistant Plasmodium yoelii nigeriensis infected Swiss Albino mice (Mus musculus) at 15 mg/kg combined with 10 mg/kg chloroquine | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA753946 | F | In vivo antimalarial activity as MST of 1 week in chloroquine-resistant Plasmodium yoelii nigeriensis infected Swiss Albino mice (Mus musculus) at 15 mg/kg | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA756429 | F | In vivo resistance reversal (control MST = 1 week) in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus) | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA754312 | F | In vivo antimalarial activity as MST of 1 week in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus) at 10 mg/kg chloroquine | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA753880 | F | In vivo parasitaemia at day 17 in chloroquine-resistant Plasmodium yoelii nigeriensis infected Swiss Albino mice (Mus musculus); Not active | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA753881 | F | In vivo resistance reversal agent in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus). Parasitemia observed on day 6-10 of treatment in Group III NI denotes nil inhibition | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA753882 | F | In vivo antimalarial activity as parasitemia at day 17 in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus) treated at day 10; No survivors | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA753883 | F | In vivo antimalarial activity as parasitemia at day 17 in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus) treated at day 10; No survivors | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA753884 | F | In vivo antimalarial activity as parasitemia at day 6 in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus); range 70-80% | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA753885 | F | In vivo antimalarial activity as parasitemia at days 6-10 in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus); range 70-80% | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA753886 | F | In vivo antimalarial activity as pretreatment parasitaemia in chloroquine-resistant Plasmodium yoelii nigeriensis infected Swiss Albino mice (Mus musculus); range 1-2% | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA753887 | F | In vivo antimalarial activity as pretreatment parasitemia in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus); range 1-2% | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA753888 | F | In vivo antimalarial activity as pretreatment parasitemia in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus); range 1-2% | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA753889 | F | In vivo resistance reversal in chloroquine-resistant Plasmodium yoelii nigeriensis infected Swiss Albino mice (Mus musculus); range is 1-2% | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA753890 | F | In vivo antimalarial activity as parasitemia at day 17 in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus) treated at day 10; No survivors | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA753891 | F | In vivo resistance reversal agent in chloroquine-resistant Plasmodium yoelii nigerienses infected Swiss Albino mice (Mus musculus). Parasitemia observed on day 6-10 of treatment in Group IV;range is 80-70% | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA857654 | F | In vitro antimalarial activity against Plasmodium yoelii NS in peter 4-day assay | Plasmodium yoelii | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA765670 | F | Heme content in chloroquine-resistant Plasmodium yoelii | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA765671 | F | Heme content after 10 days in chloroquine-resistant Plasmodium yoelii at 15 mg/kg | Plasmodium yoelii | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA765672 | F | Heme content in chloroquine-sensitive Plasmodium yoelii | Plasmodium yoelii | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!